Raphael Koch

8PUBLICATIONS
45CO-AUTHORS
Haematological tumoursRadiation therapyMolecular targetsPredictive and prognostic markersRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 19, 2025
Clonal evolution and apoptosis resistance in myelodysplastic neoplasms and acute myeloid leukemia under treatment: insights from integrative longitudinal profiling.

Paolo Mazzeo, Sarah Mae Penir, Evgenii Shumilov

|Jan 11, 2024
And Yet It Moves: Clinical Outcomes and Motion Management in Stereotactic Body Radiation Therapy (SBRT) of Centrally Located Non-Small Cell Lung Cancer (NSCLC): Shedding Light on the Internal Organ at Risk Volume (IRV) Concept.

Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing

|Jun 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.

Cristina Mastini, Marco Campisi, Enrico Patrucco

|Aug 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis.

Evgenii Shumilov, Lena Aperdannier, Nicole Schmidt

|Apr 03, 2022
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.

Evgenii Shumilov, Justin Hasenkamp, Markus Maulhardt

|Jul 02, 2021
Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.

Evgenii Shumilov, Petra Hoffknecht, Raphael Koch

Pageof 2

Frequent Collaborators

3 joint publications

David M Weinstock

3 joint publications

Evgenii Shumilov

2 joint publications

Hannes Treiber

2 joint publications

Ulrike Bacher